• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄和性别对术前心血管风险评估的影响。

Effect of age and gender on pre-operative cardiovascular risk assessment.

作者信息

Chehab Omar, Eldirani Mahmoud, Tamim Hani, Mailhac Aurelie, Makki Maha, Dakik Habib A

机构信息

Departments of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.

Biostatistics Unit, American University of Beirut Medical Center, Beirut, Lebanon.

出版信息

Perioper Med (Lond). 2022 Jun 2;11(1):23. doi: 10.1186/s13741-022-00247-2.

DOI:10.1186/s13741-022-00247-2
PMID:35650615
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9161469/
Abstract

BACKGROUND

The AUB-HAS2 Cardiovascular Risk Index is a recently published tool for pre-operative cardiovascular evaluation. It is based on six data elements: history of heart disease, symptoms of angina or dyspnea, age ≥ 75 years, hemoglobin < 12 mg/dl, vascular surgery, and emergency surgery. The objective of this study is to study the effect of age and gender on the performance of the AUB-HAS2 Index in pre-operative cardiovascular risk assessment.

METHODS

The study population consisted of 1,167,414 non-cardiac surgeries registered in the ACS NSQIP database. The population was stratified by age (≥ 40 and < 40 years old) and by gender (men and women). Each patient was given an AUB-HAS2 score of 0, 1, 2, 3, or > 3 based on the number of data elements s/he has. The outcome measure was all-cause mortality, myocardial infarction (MI), or stroke at 30 days after surgery.

RESULTS

The overall 30-day event rate was higher in patients ≥ 40 years compared to those < 40 years (2.5% vs 0.3%, P < 0.0001) and in men compared to women (2.7% vs 1.8%, P < 0.0001). In both age and gender subgroups, there was a gradual and significant increase in the outcome measure (death, MI, or stroke) as the AUB-HAS2 score increased: from ≤ 0.5% in those with a score of 0 to more than 15% in those with a score > 3 (P < 0.0001). The AUB-HAS2 Index was able to stratify risk in all subgroups into low, intermediate, and high (P < 0.0001). Receiver operating characteristic curves showed the AUB-HAS2 Index has very good discriminatory power in both age (area under the curve (AUC) of 0.81 and 0.78) and gender (AUCs of 0.79 and 0.84) subgroups.

CONCLUSION

This study extends the validation of the newly derived AUB-HAS2 Cardiovascular Risk Index to different age and gender subgroups with very good discriminative power.

摘要

背景

AUB-HAS2心血管风险指数是最近发布的一种术前心血管评估工具。它基于六个数据元素:心脏病史、心绞痛或呼吸困难症状、年龄≥75岁、血红蛋白<12mg/dl、血管手术和急诊手术。本研究的目的是探讨年龄和性别对AUB-HAS2指数在术前心血管风险评估中性能的影响。

方法

研究人群包括美国外科医师学会国家外科质量改进计划(ACS NSQIP)数据库中登记的1167414例非心脏手术患者。根据年龄(≥40岁和<40岁)和性别(男性和女性)对人群进行分层。根据每个患者拥有的数据元素数量,给予其AUB-HAS2评分为0、1、2、3或>3。观察指标为术后30天的全因死亡率、心肌梗死(MI)或中风。

结果

≥40岁患者的30天总体事件发生率高于<40岁患者(2.5%对0.3%,P<0.0001),男性高于女性(2.7%对1.8%,P<0.0001)。在年龄和性别亚组中,随着AUB-HAS2评分的增加,观察指标(死亡、MI或中风)均逐渐显著增加:评分为0的患者中≤0.5%,评分>3的患者中超过15%(P<0.0001)。AUB-HAS2指数能够将所有亚组的风险分层为低、中、高风险(P<0.0001)。受试者工作特征曲线显示,AUB-HAS2指数在年龄亚组(曲线下面积(AUC)分别为0.81和0.78)和性别亚组(AUC分别为0.79和0.84)中均具有很好的鉴别能力。

结论

本研究将新推导的AUB-HAS2心血管风险指数的验证扩展到不同年龄和性别亚组,具有很好的鉴别能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db40/9161469/a429db3f813c/13741_2022_247_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db40/9161469/1cb1615a25ac/13741_2022_247_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db40/9161469/6dc919cececa/13741_2022_247_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db40/9161469/5723e018ea9b/13741_2022_247_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db40/9161469/a429db3f813c/13741_2022_247_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db40/9161469/1cb1615a25ac/13741_2022_247_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db40/9161469/6dc919cececa/13741_2022_247_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db40/9161469/5723e018ea9b/13741_2022_247_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db40/9161469/a429db3f813c/13741_2022_247_Fig4_HTML.jpg

相似文献

1
Effect of age and gender on pre-operative cardiovascular risk assessment.年龄和性别对术前心血管风险评估的影响。
Perioper Med (Lond). 2022 Jun 2;11(1):23. doi: 10.1186/s13741-022-00247-2.
2
AUB-HAS2 Cardiovascular Risk Index: Performance in Surgical Subpopulations and Comparison to the Revised Cardiac Risk Index.AUB-HAS2 心血管风险指数:在手术亚人群中的表现与修订后的心脏风险指数的比较。
J Am Heart Assoc. 2020 May 18;9(10):e016228. doi: 10.1161/JAHA.119.016228. Epub 2020 May 10.
3
Comparison of the performance of the AUB-HAS2 Cardiovascular Risk Index in emergency vs elective surgeries.比较 AUB-HAS2 心血管风险指数在急诊与择期手术中的表现。
J Cardiol. 2024 Jul;84(1):55-58. doi: 10.1016/j.jjcc.2024.02.007. Epub 2024 Feb 20.
4
Performance of the AUB-HAS2 Cardiovascular Risk Index in vascular surgery patients.血管外科患者中 AUB-HAS2 心血管风险指数的表现。
Vasc Med. 2021 Oct;26(5):535-541. doi: 10.1177/1358863X21996806. Epub 2021 Apr 5.
5
Comparison of preoperative NT-proBNP and simple cardiac risk scores for predicting postoperative morbidity after non-cardiac surgery with intermediate or high surgical risk.术前NT-proBNP与简单心脏风险评分在预测中高危非心脏手术后并发症方面的比较
Perioper Med (Lond). 2024 May 17;13(1):44. doi: 10.1186/s13741-024-00400-z.
6
A New Index for Pre-Operative Cardiovascular Evaluation.一种新的术前心血管评估指标。
J Am Coll Cardiol. 2019 Jun 25;73(24):3067-3078. doi: 10.1016/j.jacc.2019.04.023.
7
Major adverse cardiovascular events following partial nephrectomy: a procedure-specific risk index.肾部分切除术后的主要不良心血管事件:一种特定手术风险指数
Ther Adv Urol. 2022 Mar 18;14:17562872221084847. doi: 10.1177/17562872221084847. eCollection 2022 Jan-Dec.
8
Prospective validation of the AUB-HAS2 cardiovascular risk index.AUB-HAS2心血管风险指数的前瞻性验证
Eur Heart J Qual Care Clin Outcomes. 2022 Jan 5;8(1):96-97. doi: 10.1093/ehjqcco/qcaa077.
9
Prognostic Value of Preoperative Pro-B-Type Natriuretic Peptide: Early Predictor of Cardiovascular Complications and Mortality After Major Abdominal Surgery.术前B型利钠肽原的预后价值:腹部大手术后心血管并发症和死亡率的早期预测指标
Cureus. 2020 Nov 5;12(11):e11338. doi: 10.7759/cureus.11338.
10
30 day predicted outcome in undifferentiated chest pain: multicenter validation of the HEART score in Tunisian population.30 天不明原因胸痛预测结果:HEART 评分在突尼斯人群中的多中心验证。
BMC Cardiovasc Disord. 2021 Nov 19;21(1):555. doi: 10.1186/s12872-021-02381-z.

本文引用的文献

1
Prospective validation of the AUB-HAS2 cardiovascular risk index.AUB-HAS2心血管风险指数的前瞻性验证
Eur Heart J Qual Care Clin Outcomes. 2022 Jan 5;8(1):96-97. doi: 10.1093/ehjqcco/qcaa077.
2
AUB-HAS2 Cardiovascular Risk Index: Performance in Surgical Subpopulations and Comparison to the Revised Cardiac Risk Index.AUB-HAS2 心血管风险指数:在手术亚人群中的表现与修订后的心脏风险指数的比较。
J Am Heart Assoc. 2020 May 18;9(10):e016228. doi: 10.1161/JAHA.119.016228. Epub 2020 May 10.
3
A New Index for Pre-Operative Cardiovascular Evaluation.
一种新的术前心血管评估指标。
J Am Coll Cardiol. 2019 Jun 25;73(24):3067-3078. doi: 10.1016/j.jacc.2019.04.023.
4
Impact of Gender on 30-Day Complications After Primary Total Joint Arthroplasty.性别对初次全关节置换术后30天并发症的影响。
J Arthroplasty. 2017 Aug;32(8):2370-2374. doi: 10.1016/j.arth.2017.03.001. Epub 2017 Mar 10.
5
Gender as a risk factor for adverse intraoperative and postoperative outcomes of elective pancreatectomy.性别作为择期胰腺切除术术中及术后不良结局的一个风险因素。
J Surg Oncol. 2017 Feb;115(2):131-136. doi: 10.1002/jso.24488. Epub 2016 Nov 4.
6
Age-specific performance of the revised cardiac risk index for predicting cardiovascular risk in elective noncardiac surgery.用于预测择期非心脏手术心血管风险的修订心脏风险指数的年龄特异性表现。
Circ Cardiovasc Qual Outcomes. 2015 Jan;8(1):103-8. doi: 10.1161/CIRCOUTCOMES.114.001298. Epub 2015 Jan 13.
7
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).2014年欧洲心脏病学会/欧洲麻醉学会非心脏手术心血管评估和管理指南:非心脏手术心血管评估和管理联合工作组,由欧洲心脏病学会(ESC)和欧洲麻醉学会(ESA)组成。
Eur Heart J. 2014 Sep 14;35(35):2383-431. doi: 10.1093/eurheartj/ehu282. Epub 2014 Aug 1.
8
2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2014年美国心脏病学会/美国心脏协会非心脏手术患者围手术期心血管评估和管理指南:执行摘要:美国心脏病学会/美国心脏协会实践指南工作组报告
Circulation. 2014 Dec 9;130(24):2215-45. doi: 10.1161/CIR.0000000000000105. Epub 2014 Aug 1.
9
Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons.开发和评估通用 ACS NSQIP 手术风险计算器:为患者和外科医生提供的决策辅助和知情同意工具。
J Am Coll Surg. 2013 Nov;217(5):833-42.e1-3. doi: 10.1016/j.jamcollsurg.2013.07.385. Epub 2013 Sep 18.
10
Development and validation of a risk calculator for prediction of cardiac risk after surgery.手术心脏风险预测风险计算器的开发和验证。
Circulation. 2011 Jul 26;124(4):381-7. doi: 10.1161/CIRCULATIONAHA.110.015701. Epub 2011 Jul 5.